Neighbourly Pharmacy Inc
TSX:NBLY
EV/EBIT
Enterprise Value to EBIT
Enterprise Value to EBIT (EV/EBIT) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s earnings before interest and taxes (EBIT). Considered one of the most frequently used multiples for comparisons among companies, the EV/EBIT multiple relies on operating income as the core driver of valuation.
Market Cap | EV/EBIT | ||||
---|---|---|---|---|---|
CA |
Neighbourly Pharmacy Inc
TSX:NBLY
|
831.9m CAD | 85.9 | ||
ZA |
C
|
Clicks Group Ltd
JSE:CLS
|
72.6B Zac | 0 | |
ZA |
D
|
Dis-Chem Pharmacies Ltd
JSE:DCP
|
26.9B Zac | 0 | |
US |
Walgreens Boots Alliance Inc
NASDAQ:WBA
|
14B USD | 11.1 | ||
BR |
Raia Drogasil SA
BOVESPA:RADL3
|
43B BRL | 21.2 | ||
CN |
Yifeng Pharmacy Chain Co Ltd
SSE:603939
|
45.4B CNY | 23.3 | ||
JP |
MatsukiyoCocokara & Co
TSE:3088
|
925.2B JPY | 10.7 | ||
MX |
Corporativo Fragua SAB de CV
BMV:FRAGUAB
|
84.6B MXN | 9.6 | ||
SA |
Al Nahdi Medical Company SCJSC
SAU:4164
|
17.4B SAR | 18 | ||
JP |
Cosmos Pharmaceutical Corp
TSE:3349
|
502.9B JPY | 15.5 | ||
CN |
D
|
DaShenLin Pharmaceutical Group Co Ltd
SSE:603233
|
22.8B CNY | 17.3 |
EV/EBIT Forward Multiples
Forward EV/EBIT multiple is a version of the EV/EBIT ratio that uses forecasted EBIT for the EV/EBIT calculation. 1-Year, 2-Years, and 3-Years forwards use EBIT forecasts for 1, 2, and 3 years ahead, respectively.